Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2004-11-09
2008-12-16
Seaman, D. Margaret (Department: 1625)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C546S153000
Reexamination Certificate
active
07465799
ABSTRACT:
The present invention relates to the field of anti-inflammatory substances, and more particularly to novel compounds that act as antagonists of the mammalian adhesion proteins known as selectins. In some embodiments, methods for treating selectin mediated disorders are provided which include administration of compound of Formula I:wherein the constituent variables are defined herein.
REFERENCES:
patent: 5840679 (1998-11-01), Larsen et al.
patent: 6083944 (2000-07-01), Chatterjee et al.
patent: 6232320 (2001-05-01), Stewart et al.
patent: 1 422 782 (2004-05-01), None
patent: WO 99/29705 (1999-06-01), None
patent: WO 03/001968 (2003-01-01), None
Liu, Bioorg & Med Chem Lett, vol. 11, pp. 1639-1641, 2001.
Cragoe et al., “The synthesis of 3-hydroxy-2-phenylquinoline-4, 8-dicar-boxylic acid and certain of its derivatives,”J. Org. Chem.(1953) 18:561.
Frenette et al., “Insights into selectin function from knockout mice”Thromb. Haemost(1997) 78(1):60-64.
Huo “Highly efficient, general procedure for the preparation of alkylzinc reagents from unactivated alkyl bromides and chlorides”Organic Letters(2003) 5(4):423-425.
Johnson et al., “Absence of P-selectin delays fatty streak formation in mice”J. Clin. Invest.(1997) 99:1037-1043.
Kumar et al., “Recombinant soluble form of PSGL-1 accelerates thrombolysis and prevents reocclusion in a porcine model”Circulation(1999) 99(10):1363-1369.
Lisowski et al., “Efficient synthesis of novel 3-(Het)arylanthranilic acids via a suzuki cross-coupling reaction of 7-iodoisatin with (Het)arylboronic acids in water”J. Org. Chem.(2000) 65:4193-4194.
Molenaar et al., “P-selectin as a candidate target in atherosclerosis”Biochem. Pharmacol.(2003) 66:859-866.
Pouyani et al., “PSGL-1 recognition of P-selectin is controlled by a tyrosine sulfation consensus at the PSGL-1 amino terminus”Cell(1995) 83(2):333-343.
Rewcastle et al., “Potential antitumor agents. 61. Structure-activity relationships for in vivo colon 38 activity among disubstituted 9-oxo-9H-xanthene-4-acetic acids.”J. Med. Chem.(1991) 34:217-222.
Sako et al., “A sulfated peptide segment at the amino terminus of PSGL-1 is critical for P-selectin binding”Cell(1995) 83(2):323-331.
Scalia et al., “Effect of recombinant soluble P-selectin glycoprotein ligand-1 on leukocyte-endothelium interation in vivo. Role in rat traumatic shock”Circ. Res.(1999) 84(1):93-102.
Somers et al., “Insights into the molecular basis of leukocyte tethering and rolling revealed by structures of P- and E-selectin bound to SLe(X) and PSGL-1,”Cell(2000) 103:467-479.
Takada et al., “The cytokine-adhesion molecule cascade in ischemia/reperfusion injury of the rat kidney. Inhibition by a soluble P-selectin ligand,”J. Clin. Invest.(1997) 99(11):2682-2690.
Wilkins et al., “Tyrosine sulfation of P-selectin glycoprotein ligand-1 is required for high affinity binding to P-selectin,”J. Biol. Chem.(1995) 270(39):22677-22680.
Yang et al., “Induction of a Ferroelectric Sc* Liquid Crystal Phase by an Atropisomeric Dopant Derived from 4,4′-Dihydroxy-2,2′-dimethyl-6,6′-dinitrobiphenyl”J. Am. Chem. Soc.(1996) 118(40):9557-9561.
Berge et al., “Pharmaceutical Salts,”Journal of Pharmaceutical Sciences(1977) 66(1): 1-19.
Greene et al.,Productive Groups In Organic Synthesis(1991) 2d ed, John Wiley & Sons, New York.
Marvel and HiersOrg. Synth. Coll. vol. II(1944) 2d ed. (Blatt, A.H., ed.), John Wiley & Sons, New York, pp. 165-167.
Marvel and HiersOrg. Synth. Coll. vol. I,(1941) 2d ed. (Blatt, A.H., ed.), John Wiley & Sons, New York, p. 327.
Remington's Pharmaceutical Sciences(1980) Mack Pub. Co., Easton, PA.
Boschelli et al., “Inhibition of E-selectin-, ICAM-1-, and VCAM-1-mediated cell adhesion by benzo[b]thiophene-, benzofuran-, indole-, and naphthalene-2-carboxamides: Identification of PD 144795 as an anti-inflammatory agent,”Journal of Medicinal Chemistry(1995) 38(22):4597-4614.
International Search Report dated May 11, 2005 for International Application No. PCT/US2004/037334.
Bedard Patricia W.
Camphausen Raymond T.
Debernardo Silvano L.
Jantz Kristin M.
Kaila Neelu
Seaman D. Margaret
Wyeth
LandOfFree
Methods and compositions for selectin inhibition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods and compositions for selectin inhibition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods and compositions for selectin inhibition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4044010